FDA limits use of J&J vaccine over blood clotting disorder, but experts say Pfizer, Moderna shots pose similar risk

By Julie Comber, Ph.D. | The Defender | May 6, 2022 The U.S. Food and Drug Administration (FDA) on Thursday put strict limits on the use of the Johnson & Johnson (J&J) COVID-19 vaccine, citing the risk of a blood-clotting condition the agency described as “rare and potentially life-threatening.” In a statement Thursday, the FDA said the risk of vaccine recipients […]